Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL17746698 | 0.94 | TSHR (0.46) | TSHRHPGDATMALDH1A1HCAR2 | |
| SCHEMBL251308 | 0.90 | TSHR (0.36) | TSHRHPGDALDH1A1HCAR2SMN1; SMN2 | |
| Ethyl Fumarate SCHEMBL1066889 | 0.87 | HCAR2 (0.55) | TSHRHPGDATMALDH1A1HCAR2 | |
| Acrylic Acid SCHEMBL17746670 | 0.84 | HCAR2 (0.38) | TSHRHPGDHCAR2LMNASMN1; SMN2 | |
| SCHEMBL251222 | 0.83 | NPSR1 (0.41) | TSHRALDH1A1HCAR2NPSR1MAPT | |
| SCHEMBL8197129 | 0.83 | TSHR (0.53) | TSHRHPGDATMALDH1A1HCAR2 | |
| Acrolein SCHEMBL11765426 | 0.81 | HCAR2 (0.46) | TSHRHPGDATMALDH1A1HCAR2 | |
| SCHEMBL313840 | 0.81 | HCAR2 (0.53) | TSHRHPGDATMALDH1A1HCAR2 | |
| SCHEMBL4867066 | 0.78 | TSHR (0.45) | TSHRHPGDATMALDH1A1HCAR2 | |
| SCHEMBL324971 | 0.78 | TSHR (0.58) | TSHRHPGDATMALDH1A1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124747-A1 | THERMAL BONDING FILM, METHOD FOR PRODUCING SAME, AND WATER TANK ADHESION STRUCTURE USING SAME FOR AIR-TO-WATER SOURCE HEAT PUMP | LG ELECTRONICS INC. (KR) | 2024-04-18 | — | — | US | claimed |
| EP-4293068-A1 | THERMAL BONDING FILM, METHOD FOR PRODUCING SAME, AND WATER TANK ADHESION STRUCTURE USING SAME FOR AIR-TO-WATER SOURCE HEAT PUMP | LG Electronics Inc. (KR) | 2023-12-20 | — | — | EP | claimed |
| US-11331939-B2 | Recording media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-05-17 | — | — | US | claimed |
| US-20200301296-A1 | EMULSION AGGREGATION PROCESS | XEROX CORPORATION | 2020-09-24 | — | — | US | claimed |
| US-20200180338-A1 | RECORDING MEDIA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2020-06-11 | — | — | US | claimed |
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | claimed |
| US-10570290-B2 | Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins | XEROX CORPORATION (US) | 2020-02-25 | — | — | US | claimed |
| US-10543707-B2 | Recording media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-01-28 | — | — | US | claimed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | claimed |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | XEROX CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-5928829-A | Latex processes | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0928994-A2 | Toner preparation processes | Xerox Corporation (US) | 1999-07-14 | — | — | EP | claimed |
| US-5869216-A | LATEX, AGGREGATION, FUSION/COALESCENCE, SURFACE TREATMENT WITH A SALICYLIC ACID OR A CATECHOL | XEROX CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| US-5863698-A | MIXING COLORANT COMPRISING PHOSPHATE-CONTAINING SURFACTANT, LATEX EMULSION, HEATING, STABILIZING | XEROX CORPORATION (US) | 1999-01-26 | — | — | US | claimed |
| US-5858601-A | Toner processes | XEROX CORPORATION (US) | 1999-01-12 | — | — | US | claimed |
| US-5827633-A | Toner processes | XEROX CORPORATION (US) | 1998-10-27 | — | — | US | claimed |
| US-5766818-A | Toner processes with hydrolyzable surfactant | XEROX CORPORATION (US) | 1998-06-16 | — | — | US | claimed |
| US-5766817-A | AGGREGATING COLORANT DISPERSION WITH LATEX MINIEMULSION CONTAINING POLYMER AND IONIC AND NONIONIC SURFACTANTS, COALESCING THE AGGREGATES GENERATED | XEROX CORPORATION (US) | 1998-06-16 | — | — | US | claimed |
| US-5763133-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-06-09 | — | — | US | claimed |
| US-5747215-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-05-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | TERB1, NBAS, MFAP1 | TSHR 4098/4885HPGD 2095/4885ATM 1939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.